Maschek W, Neumüller H, Pastl K, Höpfel I, Dienstl E, Böhler N, Syre G
Institut für Nuklearmedizin, Allgemeines öffentliches Krankenhaus der Stadt Linz, Osterreich.
Nuklearmedizin. 1990 Feb;29(1):19-23.
Until now the clinical identification of the affinity of monoclonal 99mTc-anti-CEA antibodies (MAK BW 250/183) on granulocytes was made with tumor cells carrying the same epitope on NCA-95 and human granulocytes in vitro. As this antibody only binds human granulocytes, animal experiments are impossible. 3 patients had their blood withdrawn within 6 h after injection, another patient had his left hip-joint biopsied after 24 h, the samples undergoing subsequent immunocytochemical dyeing. Dyeing of granulocytes all over the smears was evident whereas lymphocytes, monocytes and erythrocytes did not show any reaction. After 6 h there seemed to be a large difference between a relatively high quantity of 86% unlabelled 99mTc-MAb and 75% of immunocytochemically stainable granulocytes in the blood through an excess of binding epitopes. Six h after injection 27% of the activity were, on average, detectable in whole blood. At this time the activity in blood was reduced to an extent that scintigraphic imaging was feasible.
迄今为止,单克隆99mTc-抗CEA抗体(MAK BW 250/183)对粒细胞的亲和力在临床上是通过体外培养的携带与NCA-95相同表位的肿瘤细胞和人粒细胞来鉴定的。由于这种抗体仅与人粒细胞结合,因此无法进行动物实验。3名患者在注射后6小时内采血,另一名患者在24小时后进行左髋关节活检,对样本进行后续免疫细胞化学染色。涂片上的粒细胞染色明显,而淋巴细胞、单核细胞和红细胞未显示任何反应。6小时后,由于过量的结合表位,血液中相对大量的86%未标记的99mTc-MAb与75%免疫细胞化学可染色的粒细胞之间似乎存在很大差异。注射后6小时,平均27%的活性可在全血中检测到。此时,血液中的活性降低到了可行闪烁成像的程度。